Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the biopharmaceutical third-party logistics market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for biopharmaceutical third-party logistics market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of biopharmaceutical third-party logistics market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Biopharmaceutical Third-Party Logistics Market Categorization:

The biopharmaceutical third-party logistics market was categorized into three segments, namely supply chain (Cold Chain, Non-cold Chain), service type (Transportation, Warehousing & Storage), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The biopharmaceutical third-party logistics market was segmented into supply chain, service type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The biopharmaceutical third-party logistics market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Biopharmaceutical third-party logistics market companies & financials:

The biopharmaceutical third-party logistics market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• DHL INTERNATIONAL GMBH - DHL International GmbH is a prominent player in the field of contract logistics. The company’s portfolio of services includes air & ocean freight forwarding, international express delivery, and contract-based warehousing. With its presence in approximately 220 countries and territories worldwide, it has a truly global reach. It caters to a diverse range of sectors such as life sciences & healthcare, retail, technology, engineering & manufacturing, energy, consumer, chemicals, and auto-mobility. The organizational structure of the company comprises several divisions, namely DHL Express, DHL Freight, DHL e-commerce solutions, DHL supply chain, post & packet Deutschland, and DHL global forwarding.

• SF EXPRESS - SF Express stands at the forefront as a comprehensive logistics service provider. The company offers a range of services including sales forecasting, management of warehouses, analysis of big data, and financial management. It extends its cold chain services to numerous biopharmaceutical firms across the globe. The company's offerings encompass services like next-day delivery from cloud warehouses, same-day delivery from cloud warehouses, and services for returns & exchanges.

• UNITED PARCEL SERVICE OF AMERICA, INC. - A provider of logistics solutions, United Parcel Service of America, Inc. is, encompasses international trade facilities, package & freight transportation, and the implementation of cutting-edge technology. The company also provides forward stocking locations, distribution spaces licensed for healthcare, and shipping solutions sensitive to time and temperature. It extends its logistics services to approximately 220 countries globally. The company boasts a fleet of 125,000 motorcycles, tractors, vans, and package cars, and operates more than 1,800 facilities. Additionally, it has over 500 supply chain facilities spread across more than 125 countries. Its industry-leading products & services are offered through its widespread presence in regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• AMERISOURCEBERGEN CORPORATION - AmerisourceBergen Corporation stands at the forefront of delivering global third-party logistics services to a variety of biopharmaceutical firms. It provides both branded and generic pharmaceuticals, along with associated services, to healthcare systems & hospitals, chain retail pharmacies, medical clinics, dialysis clinics, physician practices, and a range of other healthcare clients. In addition, the company handles the transportation of biopharmaceutical products and offers services such as reimbursement consulting & inventory management to its global clientele. There are over 30 distribution centers through which the companies operate.

• DB SCHENKER - A provider of logistics services, DB Schenker incorporates contract logistics, management of supply chains, ocean freight, and air freight services. The company extends various modes of transportation services to numerous biopharmaceutical firms, including air freight services, ocean freight services, and overland transportation services. DB Schenker is recognized as a leader in healthcare logistics, trade fair logistics, special transports, and special event logistics. It delivers services in several regions, notably Europe & North America, and has operations in more than 800 locations globally.

• KUEHNE + NAGEL - A Switzerland-based company, Kuehne + Nagel is a key player in the global transportation and logistics sector. The company's operations are divided into six reportable segments—air logistics, sea logistics, sea logistics, rail freight, project logistics, and insurance. It caters to a wide array of industrial sectors, including aerospace, automotive, consumer, high-tech, industrial, perishables, and pharmaceutical & healthcare. With a network of 1,395 offices globally, the company serves approximately 400,000 customers. Its operations span across various regions such as the Americas, EMEA, and Asia Pacific.

• KERRY LOGISTICS NETWORK LIMITED - Kerry Logistics Network Limited is a global third-party logistics enterprise that offers tailor-made services to multinational corporations to improve their supply chain operations and minimize overall service costs. It functions across various sectors, including integrated logistics, international freight forwarding, seaport management, and operations & insurance brokerage, catering to a range of pharmaceutical & biopharmaceutical companies. The company has a global footprint in 59 countries & territories and has successfully established a robust presence in half of the world's emerging markets. It caters to a diverse array of industrial sectors, such as automotive, industrial & material science, pharmaceutical & healthcare, FMCG, wines & spirits, F&B trading, food & beverages, electronics & technology, fashion & technology, and art logistics. The company's services extend across Southeast Asia, India, China, Latin America, the Middle East, the CIS, and other regions.

• AGILITY LOGISTICS  - Agility is a provider of a variety of logistics services, including air, ocean, & road freight forwarding, distribution, warehousing, and specialized services in areas such as fairs & events, project logistics, and chemicals. The company's operations are primarily divided into three segments—logistics, infrastructure services, and related services. Additionally, it provides a range of subsidiary services, including airport services, commercial real estate & facilities management, customs digitization, fuel logistics, and remote infrastructure services. The lion's share of the company's revenue is generated from the logistics segment. It extends its biopharmaceutical third-party logistics services to approximately 100 countries globally.

• FEDEX CORPORATION - A multitude of patent-holding corporations across the globe are served by FedEx corporation. The company offers an extensive array of services encompassing e-commerce, transportation, and business solutions. It operates through various business divisions such as FedEx Freight, FedEx Express, FedEx Ground, and FedEx Services. It extends its services to a range of biopharmaceutical and healthcare sectors worldwide. The company provides freight delivery services to locations like the U.S. Virgin Islands and Puerto Rico, in addition to serving over 220 countries & territories globally.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Biopharmaceutical Third-Party Logistics Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Biopharmaceutical Third-Party Logistics Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.